Navigation Links
Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance

PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring the delivery of quality medical and safety services.

Hal brings to Premier Research a wealth of experience in global safety monitoring, clinical and post marketing surveillance, and drug safety compliance and training programs. For the past three years, he has served as the Executive Director and Global Head of Drug Safety at Covance Late Stage Development Services Clinical Division where he had overall responsibility for the Drug Safety organization, including accurate and timely regulatory reporting, implementation of quality assurance and quality improvement plans, implementation of training and SOP programs, measurement of productivity and workload efficiency, and client satisfaction. Prior to joining Covance in 2006, Hal led the Global Medical Affairs Compliance Training team at Wyeth. He also led the Drug Safety Training team at Wyeth's Global Safety Surveillance and Epidemiology Division. Prior to that, he led the gastrointestinal team at Astra Merck's Product Safety and Epidemiology division.

"We are very pleased to have Hal joining our team in this important role," said James Ottinger, Vice President, Global Consulting and Compliance. "His expertise and proven leadership will strengthen our team and help us expand our pharmacovigilance services to meet the evolving needs of our clients."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, CNS, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 32 offices and operates in more than 30 countries across North America and Europe employing more than 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
2. Premier Research Appoints Melissa Jones as Vice President, International Business Development
3. Premier Research Appoints Global Head of Human Resources
4. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
5. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
6. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
7. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
8. Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
9. Premier Research Announces Completion of Management Buyout
10. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
11. Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance
Post Your Comments:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology:
(Date:6/22/2016)... Md. , June 22, 2016  The American College ... Trade Show Executive Magazine as one of the ... on May 25-27 at the Bellagio in Las ... on the highest percentage of growth in each of the ... of exhibiting companies and number of attendees. The 2015 ACMG ...
(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
Breaking Biology News(10 mins):